Hand, Foot and Mouth Disease Drug pipeline Report 2020- Current Status, Phase, Mechanism, Route of Administration, Companies, and Clinical Trials of Pre-clinical and Clinical Drugs

Hand, Foot and Mouth Disease Drug pipeline Report 2020- Current Status, Phase, Mechanism, Route of Administration, Companies, and Clinical Trials of Pre-clinical and Clinical Drugs

  • October 2019 •
  • 40 pages •
  • Report ID: 5823509 •
  • Format: PDF
Hand, Foot and Mouth Disease Drug pipeline report- 2020 is an annual R&D review of Hand, Foot and Mouth Disease pipeline candidates. The report presents the current status of all major Hand, Foot and Mouth Disease therapeutic compounds. Detailed insights into Hand, Foot and Mouth Disease pipeline development, current status, companies, drug profiles and Hand, Foot and Mouth Disease preclinical and clinical trials are included.

2020 Hand, Foot and Mouth Disease Pipeline Market Insights
Hand, Foot and Mouth Disease disease overview, 2020 pipeline review, insights into leading companies, dominant mechanism of action, majority of administration route of Hand, Foot and Mouth Disease therapies, pipeline by phase and others are included.

Hand, Foot and Mouth Disease pipeline Drug profiles-
Active and inactive drug profiles covering information including drug name/synonym, sponsor/collaborators/Developer/originator, drug mechanism, route of administration, orphan drug status, NME, phase, development status, and others are included.

Hand, Foot and Mouth Disease Therapeutic Drug candidates
Both active and inactive Hand, Foot and Mouth Disease pipeline drug candidates are included in the report

Hand, Foot and Mouth Disease Clinical Trials and preclinical Studies
Hand, Foot and Mouth Disease In-vitro and In-vivo studies, discovery stage and pre-clinical stage trial details, Clinical trial titles, duration, location, phase, sponsors, and other details are provided.

Hand, Foot and Mouth Disease pipeline market developments
Hand, Foot and Mouth Disease Pipeline market news and deals including mergers, acquisitions, approvals, collaborations, trial initiations, results, investments, licensing opportunities and others are provided.

Hand, Foot and Mouth Disease pipeline companies in active development

The report analyzes Hand, Foot and Mouth Disease pipeline of the below companies-
Adimmune Corp, Beijing Minhai Biotechnology Co Ltd, Changchun BCHT, CJ HealthCare Corp, Provention Bio, Sentinext Therapeutics Sdn Bhd, Shanghai Zerun Biotechnology Co Ltd, Takeda Pharmaceutical Co Ltd

Report Coverage
- What to look out for in 2020
Drugs moving from early stage to mid-to-late stages and drugs to look after in 2020 are included

- Pipeline Snapshot
Pipeline candidate count - Drug by phase, mechanism of action, route of administration, designation and others

- Companies
8 Companies investing in Hand, Foot and Mouth Disease pipeline from discovery stage to pre-registration phase are included

- Drug profiles
Over 10 details of each Hand, Foot and Mouth Disease pipeline candidate are included

- Company Profiles
Business overview and contact details of all companies operating in the industry are provided

- Market Developments
News, Developments and other recent industry developments are included